About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

UNKNOWNNCT05002582

Carbapenem-resistant Organisms (CRO) Screening From Rectal Swabs in Patients With Hematological Diseases in China

Carbapenem-resistant Organisms (CRO) include Carbapenem-resistant Enterobacteriaceae (CRE), Carbapenem-resistant Pseudomonas aeruginosa (CRPA) and Carbapenem-resistant Acinetobacter baumannii (CRAB). ...

Lead sponsor: Sir Run Run Shaw Hospital•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Contacts

Yingzhi Fang, MD

CONTACT

+86 571 86006811 fyz4817@126.com

Sponsors

Lead Sponsor

Sir Run Run Shaw Hospital

Age

18 - 90 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•On a certain day in each chosed hospital, all the inpatients diagnosed with hematological malignancies diseases will be enrolled

Exclusion Criteria

•Patients or their legal representatives refused to enter the study
•Patients died because of hematological malignancies diseases.

Related studies

AlloCare - Support and Management of Late Effects After Allogeneic Hematopoietic Stem Cell Transplantation

NCT06281496 · Hematological Diseases

Interventions to Decrease CRE Colonization and Transmission Between Hospitals, Households, Communities and Domesticated Animals

NCT05871476 · Antibiotic Resistant Infection, Carbapenem-Resistant Enterobacteriaceae Infection

A Single-Arm, Prospective Study of TBI+BUMEL as Conditioning for SCT2 in Patients With Malignant Hematologic Diseases

NCT06548958 · Malignant Hematological Diseases

Safety and Efficacy of Fecal Microbiota Transplantation

NCT04014413 · Crohn Disease, Ulcerative Colitis, and more

Community-associated Highly-Resistant Enterobacterales

NCT03924934 · Enterobacteriaceae Infections, Community-Acquired Infections, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: August 12, 2021Terms

Trial snapshot

StatusUNKNOWN

Phase—

Enrollment5,000

Start dateJan 2021

Last updatedAug 12, 2021

Condition

Hematological Diseases Carbapenem-resistant Enterobacteriaceae Carbapenem-resistant Pseudomonas Aeruginosa Carbapenem-resistant Acinetobacter Baumannii

Locations shown

Sir Run Run Shaw Hospital

Hangzhou, Zhejiang

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 12, 2021Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions